Mazen Dimachkie

Professor & Neuromuscular Division Director

University of Kansas Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Mazen Dimachkie is a Professor and the Neuromuscular Division Director at the University of Kansas Medical Center in the United States. His research focuses on neuromuscular disorders, including the efficacy of immunoglobulin therapies, innovative outcome measures in myasthenia gravis clinical trials, and the development of patient-reported outcome scales for Pompe disease. He has contributed significantly to the understanding and treatment of conditions such as dermatomyositis and Guillain-Barré syndrome.

Articles (14)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

James Howard

Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Byron J. Gajewski

UNITED STATES

View details

steven vernino

University of Texas Southwestern Medical Center

UNITED STATES

View details

Jaya Trivedi

Professor

University of Texas Southwestern Medical School

UNITED STATES

View details

Filip Eftimov

NETHERLANDS

View details

Pedro Machado

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mazen Dimachkie

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study

Neuromuscular Junction Disorders

Study to Assess Content Validity and Interrater and Intrarater Reliability of the Inclusion Body Myositis Functional Rating Scale

Database Evaluation for Muscle and Nerve Diseases - DEMAND: An academic neuromuscular coding system

Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials

Measurement Properties of 2 Novel PROs, the Pompe Disease Symptom Scale and Pompe Disease Impact Scale, in the COMET Study

Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome

Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN

Bike and Biopsy to the Diagnosis

Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease

Predicting Outcome in Guillain-Barré Syndrome

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis

Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices

Teaching NeuroImage: Immune Checkpoint Inhibitor–Related Fasciitis and Myositis With Perifascicular Atrophy

Collaborators (6)

James Howard

Byron J. Gajewski

steven vernino

Jaya Trivedi

Filip Eftimov

Pedro Machado

Make your next move.